Cargando…

Progenitor cell secretory products exert additive renoprotective effects when combined with ace inhibitors in experimental CKD

HYPOTHESIS/INTRODUCTION: Renal fibrovascular injury often persists in chronic kidney disease patients treated with renin-angiotensin system blockers. Intriguingly, early outgrowth cell-derived factor infusion also inhibits chronic renal injury. We sought to determine whether early outgrowth cell-der...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kepecs, David M, Yuen, Darren A, Zhang, Yanling, Thai, Kerri, Connelly, Kim A, Gilbert, Richard E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5843926/ https://www.ncbi.nlm.nih.gov/pubmed/27638853 http://dx.doi.org/10.1177/1470320316668434

Ejemplares similares

Repeated treatment with bone marrow cell secretory products maintains long-term renoprotection in experimental chronic kidney disease: a placebo-controlled trial
por: Yuen, Darren A., et al.
Publicado: (2015)

Early-Outgrowth Bone Marrow Cells Attenuate Renal Injury and Dysfunction via an Antioxidant Effect in a Mouse Model of Type 2 Diabetes
por: Zhang, Yanling, et al.
Publicado: (2012)

Sodium-Glucose Linked Cotransporter-2 Inhibition Does Not Attenuate Disease Progression in the Rat Remnant Kidney Model of Chronic Kidney Disease
por: Zhang, Yanling, et al.
Publicado: (2016)

Renoprotection and the Bardoxolone Methyl Story – Is This the Right Way Forward? A Novel View of Renoprotection in CKD Trials: A New Classification Scheme for Renoprotective Agents
por: Onuigbo, Macaulay
Publicado: (2013)

Renoprotective effects of combining ACE inhibitors and statins in experimental diabetic rats
por: Mudagal, M., et al.
Publicado: (2011)

Synergic Renoprotective Effects of Combined ASC Therapy with RAAS Blockade in Experimental Advanced CKD
por: Maires, Marina P. C., et al.
Publicado: (2022)

Annexin A1 exerts renoprotective effects in experimental crescentic glomerulonephritis
por: Labes, Robert, et al.
Publicado: (2022)

Renoprotection with indapamide, additional feature to look for
por: Pande, Arindam
Publicado: (2017)

Additive effects of intensive BP control and ACE inhibition on suppression of proteinuria in patients with CKD
por: Lopez, Rafael, et al.
Publicado: (2023)

Renoprotective effect of oral rehydration solution III in exertional heatstroke rats
por: Lin, Yufang, et al.
Publicado: (2019)

The association of ACE gene polymorphism with diabetic kidney disease and renoprotective efficacy of valsartan
por: Wang, Yuying, et al.
Publicado: (2016)

Dual inhibition of sodium–glucose linked cotransporters 1 and 2 exacerbates cardiac dysfunction following experimental myocardial infarction
por: Connelly, Kim A., et al.
Publicado: (2018)

Renoprotective effects of combined SGLT2 and ACE inhibitor therapy in diabetic Dahl S rats
por: Kojima, Naoki, et al.
Publicado: (2015)

Dipeptidyl Peptidase IV Inhibition Exerts Renoprotective Effects in Rats with Established Heart Failure
por: Arruda-Junior, Daniel F., et al.
Publicado: (2016)

Soy Phospholipids Exert a Renoprotective Effect by Inhibiting the Nuclear Factor Kappa B Pathway in Macrophages
por: Ohta, Satoshi, et al.
Publicado: (2022)

Endothelial Progenitor Cells in Acute Ischemic Kidney Injury: Strategies for Increasing the Cells' Renoprotective Competence
por: Patschan, D., et al.
Publicado: (2011)

Renoprotective effects of garlic
por: Nasri, Hamid
Publicado: (2013)

Renoprotective effects of metformin
por: Nasri, Running Hamid
Publicado: (2013)

The renoprotective effects of sulodexide
por: Olde Engberink, Rik HG, et al.
Publicado: (2016)

Osteocrin, a bone-derived humoral factor, exerts a renoprotective role in ischemia–reperfusion injury in mice
por: Nishiguchi, Yoshihiko, et al.
Publicado: (2021)

Renoprotective effects of green tea
por: Hajian, Shabnam
Publicado: (2013)

Possible renoprotective effects of dabigatran
por: Karahan, Oğuz
Publicado: (2015)

Early renoprotection by anemia correction
por: Kuriyama, Satoru
Publicado: (2018)

Mineralocorticoid receptor blockade for renoprotection
por: Cha, Dae Ryong
Publicado: (2018)

Mesenchymal stem cells exert renoprotection via extracellular vesicle-mediated modulation of M2 macrophages and spleen-kidney network
por: Shimamura, Yuko, et al.
Publicado: (2022)

Does Chronic Kidney Disease–Induced Cognitive Impairment Affect Driving Safety?
por: Kepecs, David M., et al.
Publicado: (2018)

Molecular Mechanisms of Curcumin Renoprotection in Experimental Acute Renal Injury
por: Fan, Youling, et al.
Publicado: (2017)

Additive Renoprotection by Pioglitazone and Fenofibrate against Inflammatory, Oxidative and Apoptotic Manifestations of Cisplatin Nephrotoxicity: Modulation by PPARs
por: Helmy, Mai M., et al.
Publicado: (2015)

ACE2/ACE imbalance and impaired vasoreparative functions of stem/progenitor cells in aging
por: Joshi, S., et al.
Publicado: (2020)

Nitric Oxide: Renoprotective in Cardiac Surgery!
por: Magoon, Rohan, et al.
Publicado: (2020)

Renoprotective Effects of DPP-4 Inhibitors
por: Kawanami, Daiji, et al.
Publicado: (2021)

Empagliflozin Improves Diastolic Function in a Nondiabetic Rodent Model of Heart Failure With Preserved Ejection Fraction
por: Connelly, Kim A., et al.
Publicado: (2019)

Role of the eNOS-NO System in Regulating the Antiproteinuric Effects of VEGF Receptor 2 Inhibition in Diabetes
por: Advani, Andrew, et al.
Publicado: (2013)

Physical Activity and Inhibition of ACE Additively Modulate ACE/ACE-2 Balance in Heart Failure in Mice
por: Tyrankiewicz, Urszula, et al.
Publicado: (2021)

Hyperglycemia and Renal Mass Ablation Synergistically Augment Albuminuria in the Diabetic Subtotally Nephrectomized Rat: Implications for Modeling Diabetic Nephropathy
por: Chen, Li-Hao, et al.
Publicado: (2012)

Load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction
por: Connelly, Kim A., et al.
Publicado: (2020)

SIRT1 activation attenuates α cell hyperplasia, hyperglucagonaemia and hyperglycaemia in STZ-diabetic mice
por: Zhang, Yanling, et al.
Publicado: (2018)

Tamoxifen associated to the conservative CKD treatment promoted additional antifibrotic effects on experimental hypertensive nephrosclerosis
por: Fanelli, Camilla, et al.
Publicado: (2023)

ACE Inhibitor/Angiotensin Receptor Blocker Use Patterns in Advanced CKD and Risk of Kidney Failure and Death
por: Arora, Nayan, et al.
Publicado: (2020)

Renovascular and renoprotective properties of telmisartan: clinical utility
por: Ladino, Marco, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_348t11em8l24k5tdf0vohc12gs